Get all your news in one place.
100's of premium titles.
One app.
Start reading
Zenger
Zenger
Vandana Singh

Global Pharma Has $700B For M&A And Investments – From AI To Obesity Drugs

Goldman Sachs logo displayed on a smartphone with stock market percentages on the background. They recently compiled a research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. OMAR MARQUES/SOPA IMAGES/LIGHTROCKET VIA GETTY IMAGES.

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments.

This significant financial reserve will be crucial as patents for some of the industry’s blockbuster drugs are on the expiration cliff.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.